FDA Investigator Mary E Farbman, PhD

Mary E Farbman, PhD has conducted inspections on 13 sites in 7 countries as of 22 Apr 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
13
Last Inspection Date:
22 Apr 2013
Investigator Role:
FDA Investigator
Redica ID:
100004517
Countries of Inspections:
United Kingdom of Great Britain and Northern Ireland, Belgium, Germany, United States of America, Austria, Spain, Israel
FDA Investigators that have inspected at least one site in common with Mary E Farbman, PhD:
Ademola O Daramola, Alice S Tsao, Amy Devlin, PhD, Anastasia G Lolas, Andrea Siegel, PhD, Anita Narula, PhD, Anjali Shukla, PhD, Antonina Aydanian, Barbara Janine Breithaupt, Bo Chi, PhD, Bonita S Chester, Brenda W Uratani, PhD, Brian M Janelsins, PhD, Brooke K Higgins, Burnell M Henry, Carolyn A Renshaw, Chaltu Nwakijra, Christian D Lynch (CDL), Christina V Santos, Christopher R Czajka, Concepcion Cruz, Jr, Cynthia Jim, CSO, Dawn E Barkans, Dennis Cantellops Paite, Diane L Raccasi, Donald C Obenhuber, PhD, Dr. Barbara D Paul, PhD, Dr. Carmelo Rosa, Dr. Ralph M Bernstein, PhD, Dr. Zhihao Qiu (Peter), PhD, Eric L Dong, BS, Frances Namuswe, PhD, Hector A Carrero, Heika R Tait, Holly Brevig, Howard Anderson, PhD, Ivis L Negron, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, Jee Chung, PhD, Jennifer Swisher, PhD, Jonathan W Chapman, Jose Acruz Gonzalez, Jose M Cayuela, Joshua P Wireman, Julianne C Mccullough, Kalavati Suvarna, PhD, Karen E D'orazio, Kathy Lee, Kenneth O Gee, PhD, Kevin A Gonzalez, Kim Lthomas Cruse, Larry K Austin, Laurel A Beer, Leonard H Lavi, Libia M Lugo, Linda Thai, Lori J Silverstein, LT Richard A Lyght, Lynda L Perry, PhD, Madushini Dharmasena, PhD, Maria Cecilia Tami, PhD, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Maria Pkelly Doggett, MBA, Marjorie A Shapiro, PhD, Mark C Saale, Mark W Babbitt, Marvin D Jones, Maryam Tabatabaie, Michael A Charles, Michael L Casner, Michael Shanks, MS, Mihaly S Ligmond, Mra Davism, Mra Mcculloughj, Mra Munizn, Nebil A Oumer, Nicholas A Violand, Noreen Muñiz, Nutan Mytle, Omotunde O Osunsanmi, Pal S Mayasandra, Pankaj H Amin, Parul M Patel, Patricia D Stahnke, Patricia F Hughes, PhD, Paul A Bonneau, Peggy M Speight, Prabhu P Raju, Prajakta A Varadkar, Rachel C Harrington, Ram Sihag, PhD, Raquel Gonzalez Rivera, Ravichandran Veerasamy, PhD, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard Ledwidge (nmi), PhD, Riley C Myers, PhD, Robert J Ham, Roger F Zabinski, Rose Ashley, Russell J Glapion, Sang Bong Lee, Sangeeta M Khurana, PhD, Santos E Camara, Scott R Nichols, PhD, Scott T Ballard, Sean Fitzsimmons, Shadia Zaman, PhD, Stephanie A Slater, MS, Steven E Bowen, PhD, Steven E Kane, Steven Fong, MS, PhD, Steven M Weinman, Susan T Hadman, Tara L Greene, Teegan Dellibovi Ragheb, PhD, Thomas J Arista, Thuy T Nguyen, LCDR, Toyin B Oladimeji, Tracy Denison, PhD, Victoria A Wagoner, Vilmary Negron Rodriguez, Wayne E Seifert, Wendy G Tan, PhD, Xiaoshi N Wang, Yumi J Hiramine

Mary E Farbman, PhD's Documents

Publish Date Document Type Title
May, 2011 FDA 483 SEAGEN INC. - Form 483, 2011-05-19
April, 2013 FDA 483 Boehringer Ingelheim RCV GmbH & Co KG - Form 483, 2013-04-26

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more